Breyanzi
-
BeHealth News
Nuevos avances en la terapia CAR T para pacientes con linfoma
Bristol Myers Squibb (BMS) anunció recientemente que el ensayo clínico TRANSCEND FL en fase 2, evaluando Breyanzi® (lisocabtagene maraleucel) en…
Bristol Myers Squibb (BMS) anunció recientemente que el ensayo clínico TRANSCEND FL en fase 2, evaluando Breyanzi® (lisocabtagene maraleucel) en…
| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |